Overview

Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
A Prospective Randomized, Multi-center study to assess the Safety and Efficacy of Mucosta (Rebamipide), in combination with Omeprazole as adjuvant therapy in Gastric Ulcer Patients.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pakistan Limited
Treatments:
Omeprazole
Rebamipide